AlloVir, Inc.

NasdaqCM:ALVR Stock Report

Market Cap: US$48.1m

AlloVir Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ALVR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Feb 25SellUS$1,068Edward MillerIndividual106US$10.08
21 Feb 25SellUS$3,053Vikas SinhaIndividual303US$10.08
21 Feb 25SellUS$967Brett HagenIndividual96US$10.08
23 Jan 25SellUS$1,226Vikas SinhaIndividual129US$9.94
23 Jan 25SellUS$342Brett HagenIndividual36US$9.94
23 Jan 25SellUS$494Edward MillerIndividual52US$9.94
10 Jan 25SellUS$146Brett HagenIndividual14.43US$10.12
10 Jan 25SellUS$431Vikas SinhaIndividual42.57US$10.12
10 Jan 25SellUS$180Edward MillerIndividual17.78US$10.12
19 Nov 24SellUS$304Brett HagenIndividual24.09US$12.62
19 Nov 24SellUS$237Edward MillerIndividual18.78US$12.62
19 Nov 24SellUS$4,775Diana BrainardIndividual378.52US$12.62
19 Nov 24SellUS$1,748Vikas SinhaIndividual138.52US$12.62
05 Nov 24SellUS$1,431Brett HagenIndividual71.96US$19.89
05 Nov 24SellUS$4,442Vikas SinhaIndividual223.3US$19.89
05 Nov 24SellUS$9,176Diana BrainardIndividual461.26US$19.89
05 Nov 24SellUS$1,965Edward MillerIndividual98.78US$19.89
22 Oct 24SellUS$746Brett HagenIndividual41.96US$17.92
22 Oct 24SellUS$1,083Edward MillerIndividual60.91US$17.92
22 Oct 24SellUS$2,649Vikas SinhaIndividual149.04US$17.92
21 Oct 24SellUS$7,597Diana BrainardIndividual424US$17.92
03 Oct 24SellUS$245Brett HagenIndividual13.09US$18.74
03 Oct 24SellUS$1,216Diana BrainardIndividual64.91US$18.74
03 Oct 24SellUS$307Edward MillerIndividual16.39US$18.74
03 Oct 24SellUS$766Vikas SinhaIndividual40.87US$18.74
20 Aug 24SellUS$3,996Diana BrainardIndividual234.35US$17.05
19 Aug 24SellUS$413Brett HagenIndividual23.65US$17.47
19 Aug 24SellUS$2,348Diana BrainardIndividual134.39US$17.47
19 Aug 24SellUS$321Edward MillerIndividual18.35US$17.47
19 Aug 24SellUS$2,399Vikas SinhaIndividual137.35US$17.47
05 Aug 24SellUS$1,243Brett HagenIndividual73.57US$16.90
05 Aug 24SellUS$7,970Diana BrainardIndividual471.61US$16.90
05 Aug 24SellUS$1,707Edward MillerIndividual101US$16.90
05 Aug 24SellUS$3,858Vikas SinhaIndividual228.3US$16.90
22 Jul 24SellUS$715Brett HagenIndividual41.74US$17.25
22 Jul 24SellUS$1,035Edward MillerIndividual60.48US$17.25
22 Jul 24SellUS$2,530Vikas SinhaIndividual147.83US$17.25
19 Jul 24SellUS$7,299Diana BrainardIndividual423.09US$17.25
02 Jul 24SellUS$219Brett HagenIndividual13.22US$16.56
02 Jul 24SellUS$1,072Diana BrainardIndividual64.74US$16.56
02 Jul 24SellUS$676Vikas SinhaIndividual40.83US$16.56
02 Jul 24SellUS$273Edward MillerIndividual16.48US$16.56
21 May 24SellUS$4,080Diana BrainardIndividual223.87US$18.22
17 May 24SellUS$405Brett HagenIndividual23.52US$17.23
17 May 24SellUS$315Edward MillerIndividual18.26US$17.23
17 May 24SellUS$2,355Vikas SinhaIndividual136.65US$17.23
17 May 24SellUS$2,304Diana BrainardIndividual133.7US$17.23
03 May 24SellUS$1,271Brett HagenIndividual69.43US$18.31
03 May 24SellUS$1,840Edward MillerIndividual100.48US$18.31
03 May 24SellUS$3,946Vikas SinhaIndividual215.52US$18.31
03 May 24SellUS$8,151Diana BrainardIndividual445.22US$18.31
22 Apr 24SellUS$715Brett HagenIndividual41.43US$17.26
22 Apr 24SellUS$2,534Vikas SinhaIndividual146.87US$17.26
22 Apr 24SellUS$1,038Edward MillerIndividual60.13US$17.26
19 Apr 24SellUS$7,207Diana BrainardIndividual417.44US$17.26
02 Apr 24SellUS$217Brett HagenIndividual12.22US$17.76
02 Apr 24SellUS$683Vikas SinhaIndividual38.48US$17.76
02 Apr 24SellUS$1,183Diana BrainardIndividual66.65US$17.76
02 Apr 24SellUS$284Edward MillerIndividual16US$17.76

Insider Trading Volume

Insider Buying: ALVR insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ALVR?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms286,8335.76%
Hedge Funds487,6099.8%
Public Companies723,27314.5%
Private Companies730,99514.7%
Institutions755,19115.2%
Individual Insiders904,36518.2%
General Public1,087,52921.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 75.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.6%
ElevateBio, LLC
724,989US$7.0m0%no data
14.5%
Gilead Sciences, Inc.
723,273US$7.0m0%no data
9.8%
Octagon Capital Advisors LP
487,609US$4.7m0.12%0.85%
8.64%
Morana Jovan-Embiricos
430,144US$4.2m0%no data
5.76%
Artal Group S.A.
286,833US$2.8m0%0.09%
2.76%
John Wilson
137,299US$1.3m0%no data
2.65%
Millennium Management LLC
131,903US$1.3m-7.64%no data
2.46%
David Hallal
122,632US$1.2m0%no data
2.31%
The Vanguard Group, Inc.
115,087US$1.1m0%no data
2.08%
Juan Vera
103,258US$998.5k0%no data
1.92%
Cresset Asset Management, LLC
95,565US$924.1k0%no data
1.67%
Redmile Group, LLC
82,955US$802.2k0%0.06%
0.87%
Vikas Sinha
43,331US$419.0k2.03%no data
0.63%
Diana Brainard
31,450US$304.1k106%no data
0.58%
Jacobs Levy Equity Management Inc
28,887US$279.3k0%no data
0.55%
BlackRock, Inc.
27,516US$266.1k0%no data
0.51%
Geode Capital Management, LLC
25,425US$245.9k-0.13%no data
0.48%
Tang Capital Management, LLC
24,011US$232.2k0%0.01%
0.43%
Two Sigma Advisers, LP
21,586US$208.7k-2.33%no data
0.39%
Woodline Partners LP
19,646US$190.0k0%no data
0.38%
Edward Miller
19,074US$184.4k2.17%no data
0.36%
EcoR1 Capital, LLC
17,769US$171.8k-96.4%0.01%
0.35%
RBF Capital LLC
17,391US$168.2k-10.9%0.01%
0.33%
Renaissance Technologies LLC
16,502US$159.6k-51.1%no data
0.3%
Squarepoint OPS LLC
14,693US$142.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/13 21:52
End of Day Share Price 2025/03/13 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AlloVir, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason ZemanskyBofA Global Research
Anupam RamaJ.P. Morgan
Christopher RaymondPiper Sandler Companies